Skip to Content
Opening Bell

Earnings

Wednesday, August 5

Eli Lilly and Co · Q2 2026

LLY · Healthcare · Pharmaceuticals

Lilly grew revenue 48% year over year to $22.97 billion and lifted its full-year revenue outlook by roughly $3 billion; the stock rose 4.9%, but the real debate is not about growth — it is about how long the price erosion and the slow start of the oral pill will last.

▲ Revenue 48%EPS + 27%▲ Stock 4.9%
85
BUY

Upcoming Earnings

MUSep 30 · After Close$32.21
ORCLSep 10$1.78
COSTSep 24 · After Close$6.69
ACNOct 1 · After Close$3.21
ADBESep 10 · After Close$6.20
Go to Calendar →

Latest Earnings Analyses

AllThis WeekSemiconductorsTechnologyIndustrialsHealth CareMedia & TelecomEnergyConsumerMaterials
By DateBy ScoreBy Reaction
SymbolReportedRevenue · YoYEPS vs EstimateShare ReactionScoreVerdict
LLYQ2 2026Aug 5 · Pre-Market23.0 B $ ▲ 48%$8.38 · + 27%▲ 4.9%85BUY
AMGNQ2 2026Aug 4 · After Close10.1 B $ ▲ 10%$6.29 · + 12%▲ 4.6%78BUY
ABBVQ2 FY2026Jul 31 · Pre-Market17.0 B $ ▲ 10%$3.65▼ 2.5%74BUY
MRKQ2 2026Aug 4 · Pre-Market16.6 B $ ▲ 5%− $0.13▲ 0.2%73HOLD

Analyses are published ~1 hour after a company reports.

To Understand This

Earnings Reports: What to Read, HowThe book opens once a quarter — and the market really only reads three lines.P/E and the Valuation RatiosYou can't tell whether a stock is cheap or expensive by looking at its price.